Transactions


DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided

Clear all Clear

Download results

Showing 821 to 830 of 5658 Results

July 07, 2022
France

Safran enters into exclusive discussions to acquire Orolia, a world leader in Resilient Positioning, Navigation and Timing

Undisclosed

July 07, 2022
France

Safran enters into exclusive discussions to acquire Orolia, a world leader in Resilient Positioning, Navigation and Timing

Undisclosed

July 05, 2022
France

I2PO and Deezer reached definitive agreement for a business combination to publicly list the leading global music streaming services platform

$1.1 Billion

July 04, 2022
Australia, Japan

Komatsu announces agreement to acquire Mine Site Technologies

Undisclosed

July 04, 2022
United Kingdom, Italy

City Football Group, the world’s leading private owner and operator of football clubs with ownership of eleven clubs globally, including Manchester City FC, has acquired 80% stake of Palermo Football Club

Undisclosed

July 01, 2022
United Kingdom, United States

GSK to acquire Sierra Oncology

$1.9 Billion

July 01, 2022
United States

Sale of AllCells to Discovery Life Scienes

Undisclosed

June 30, 2022
France, Ireland

eir and InfraVia announce a partnership aimed at accelerating fibre-to-the-home roll-out across Ireland

Undisclosed

June 30, 2022
France, Netherlands

Equistone realises Fund V investment in Sicame through inaugural continuation fund deal

Undisclosed

June 30, 2022
France

The French specialty pharmaceutical company Juvisé Pharmaceuticals has successfully completed a €400M refinancing following the acquisition of the worldwide rights of Pylera®, an antimicrobial tri-therapy indicated for gastro-intestinal Helicobacter pylori infections

$418 Million